Novartis Gets Zometa Jaw Injury Suit Thrown Out In Calif.
By Daniel Wilson (August 20, 2014, 6:50 PM EDT) -- A California federal judge on Tuesday dismissed for the second time a suit accusing Novartis Pharmaceuticals Corp.'s bone drug Zometa of causing jaw injuries, ruling the plaintiff could not use Maryland law to skirt a California statute of limitations on the case.
A Maryland federal court had adequately ruled that California law and its relevant two-year statute of limitations applied, not Maryland's three-year statute of limitations, when it transferred plaintiff Michel Hendrix's case to California, meaning Hendrix's case must be dismissed as time-barred — the same as his original California suit — U.S. District Judge Michael W. Fitzgerald ruled.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!